In The News:
Oncobiologics and inVentiv Health Form Strategic Biosimilars Partnershipmore >
Huahai and Oncobiologics Create Broad Biosimilars Partnershipmore >
Oncobiologics announces Agreement to utilize XOMA's Fully Human Antibody Libraries for Discovery Platformmore >
Pharmaceutical Processing features Oncobiobiologics in Cover Storymore >

What We Do

Oncobiologics is pursuing a balanced strategy focused on global high-value biosimilars and innovative biotherapeutics.  We are committed to advancing biotherapeutics to treat serious diseases, including cancer and immune disorders by leveraging proprietary technologies and expert science and engineering.

Oncobiologics was formed by a team of eminent scientists from leading global pharmaceutical organizations and our unique business model leverages technical and business partnerships with global leaders...more >

Our Pipeline


view full size >

Company Highlights

  • A balanced strategy focused on global high-value biosimilars and novel biotherapeutics.
  • Biosymphony™: A unique consortia approach to biosimilars development and commercialization, leveraging best-in-class global partners.
  • An integrated discovery, development and clinical manufacturing engine capable of rapidly developing therapeutic assets.
  • First biosimilar asset expected to be in clinic during Q4-2013.
  • Established by eminent scientists from the world’s leading biotechnology organizations.
  • An energetic, collaborative culture.

Join Oncobiologics

Oncobiologics is a dynamic, inspiring workplace where we seek best-in-class candidates to join our existing team of renowned specialists. To learn more about opportunities with our team, please visit our careers page... more >